Scientific deep-dive
The Fat Pads in Your Ears
Your eustachian tube is held closed partly by fatty cushions. Two cases describe it staying open after weight loss on a GLP-1, and the adverse event database records the symptom zero times.
Your eustachian tube is held closed partly by small fatty cushions. Lose enough fat and it can stay open, which makes your own voice and breathing boom inside your head. Two published cases describe exactly that after starting a GLP-1, with endoscopy confirming the cushions had thinned.[1] Then the authors searched the FDA’s adverse event database and found the symptom reported zero times.
An elegant mechanism
The eustachian tube connects the middle ear to the back of the throat and equalizes pressure. It is normally shut, opening briefly when you swallow or yawn. Part of what keeps it shut is bulk in the surrounding tissue, including fat.
When that bulk is lost, the tube can become patulous, or stuck open. The result is autophony: your own voice, your breathing, sometimes your heartbeat, transmitted directly into the middle ear. People describe it as speaking into a barrel. It is not dangerous, but it is unpleasant, and it is a known consequence of rapid weight loss from any cause.
In the two cases reported here, nasal endoscopy confirmed significant loss of tissue bulk in the anterior and posterior cushions of the tube. This was seen directly, not inferred.
The check that did not confirm it
| Event | Reports |
|---|---|
| Hypoacusis (reduced hearing) | 515 |
| Vertigo | 203 |
| Deafness | 97 |
| Tinnitus | 93 |
| Ear pain | 22 |
| Motion sickness | 21 |
| Hyperacusis | 5 |
| Ear fullness | 2 |
| Autophony | 0 |
Note also what dominates that list. More than half of all otologic reports are hypoacusis (reduced hearing), which is a different problem from a tube that will not close, and would not be produced by the mechanism described above. What the newer studies say about reduced hearing and tinnitus is in GLP-1 tinnitus and hearing loss.
Why publishing both halves is the right thing to do
A beautiful mechanism plus two cases is a hypothesis. The database was the test.
It would have been easy to publish the cases and the anatomy and stop. The mechanism is coherent, the endoscopy is convincing, and nobody would have checked. Reporting the zero alongside them is what makes this a useful paper rather than a persuasive one.
So the question is unresolved. A specific, visible, anatomically confirmed mechanism exists in two people. Whether it happens at any meaningful rate is not answerable from a database that would probably not capture it.
One further oddity, consistent with something we have found before: the largest count of potentially tube-related events belongs to dulaglutide, at 417, not to the drugs producing the most weight loss and attracting the most attention. If fat loss around the tube were driving this, that is not the ranking you would expect.
What to do if this is happening to you
- It is not dangerous, and it is not imaginary. Patulous eustachian tube dysfunction is a recognized condition with a recognized cause.
- How long it lasts is not established. The cases describe tissue lost from the cushions, and neither they nor the database say how often it resolves.
- An ear, nose and throat clinician can see it. The endoscopy in these cases showed the tissue directly, so this is a symptom with an objective finding behind it.
- Say what you take. The connection is obscure enough that a clinician may not raise it, and rapid weight loss is the relevant history.
This is a minor problem in a field full of major ones. It appears here because a symptom with a mechanism and no reports is a good example of how to hold an uncertain finding, and because someone experiencing it is currently unlikely to find anything written about it at all.
Frequently Asked Questions
References
- 1.Pak KY, Cutri RM, Nadeem W, et al. GLP-1 Receptor Agonist Induced Eustachian Tube Dysfunction: Database and Systematic Review of Otolaryngologic Adverse Events Otology & Neurotology. 2025. PMID: 39666743.
Compare the sellers
Related research
What These Hormones Do Without a Pancreas
To isolate what the gut hormones do outside the pancreas, researchers studied twelve people who no longer have one, and blocked the receptors. The one clear result was about bone.
6 min read
Uric Acid and Two Answers
Two studies asked whether these drugs lower uric acid. Both said yes. One found the effect 72.7% explained by weight loss; the other found it independent of weight loss.
7 min read
Taste Got Better, Not Worse
People on these drugs routinely say food tastes wrong. A trial measured taste objectively, biopsied participants' tongues and scanned their brains, and found taste recognition improved.
6 min read
The Line Is Drawn by Surgery
A meta-regression found study arms with greater average weight loss had higher rates of fatty liver disease resolving. The authors say plainly it cannot establish cause, and a handful of surgical arms are pulling the line.
6 min read
Why the Appetite Comes Back
Weight loss slows and appetite for particular foods creeps back. A Science study found a specific brain circuit doing exactly that, in mice, whose neurons can be switched off with light.
6 min read
Is It Just the Weight Loss?
Every benefit reported for these drugs runs into the same question. A post hoc analysis of the SURMOUNT-OSA trials tried to separate the drug from the weight, and found the sleep apnea improvement doing work of its own.
7 min read
Where to get GLP-1 online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $149/mo + care fee
Get started →WellMedRx
Comparing compounded and brand GLP-1 plans with a published state list
From $49/mo
Get started →altRX
Compounded semaglutide from $89/month at the same price at every dose
From $89/mo
Get started →